Bup‐Woo Kim

959 total citations
41 papers, 708 citations indexed

About

Bup‐Woo Kim is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Bup‐Woo Kim has authored 41 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 28 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Oncology. Recurrent topics in Bup‐Woo Kim's work include Thyroid Cancer Diagnosis and Treatment (27 papers), Thyroid and Parathyroid Surgery (22 papers) and Head and Neck Anomalies (12 papers). Bup‐Woo Kim is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (27 papers), Thyroid and Parathyroid Surgery (22 papers) and Head and Neck Anomalies (12 papers). Bup‐Woo Kim collaborates with scholars based in South Korea, Puerto Rico and Türkiye. Bup‐Woo Kim's co-authors include Hang‐Seok Chang, Yong Sang Lee, Cheong Soo Park, Seok‐Mo Kim, Soo Young Kim, Hojin Chang, Soon Won Hong, Jae Hyun Park, Jae Yun Lim and Y. Choi and has published in prestigious journals such as PLoS ONE, Medicine and Clinical Endocrinology.

In The Last Decade

Bup‐Woo Kim

40 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bup‐Woo Kim South Korea 17 541 420 102 97 80 41 708
Andreas Muth Sweden 17 525 1.0× 604 1.4× 100 1.0× 89 0.9× 69 0.9× 48 857
Jingqiang Zhu China 17 507 0.9× 316 0.8× 158 1.5× 143 1.5× 66 0.8× 47 740
Francesca Torresan Italy 14 356 0.7× 273 0.7× 82 0.8× 94 1.0× 93 1.2× 50 578
Anthony Glover Australia 17 522 1.0× 409 1.0× 282 2.8× 128 1.3× 66 0.8× 70 970
Kiyomi Y. Hames Japan 14 549 1.0× 266 0.6× 74 0.7× 116 1.2× 74 0.9× 33 722
Rixiang Gong China 21 671 1.2× 458 1.1× 162 1.6× 193 2.0× 62 0.8× 55 936
Eui Young Kim South Korea 16 832 1.5× 440 1.0× 81 0.8× 92 0.9× 139 1.7× 36 939
Zhen-gang Xu China 16 378 0.7× 478 1.1× 76 0.7× 152 1.6× 82 1.0× 116 809
Kenichi Matsuzu Japan 18 815 1.5× 428 1.0× 159 1.6× 173 1.8× 91 1.1× 57 1.0k
C Pagetta Italy 15 544 1.0× 582 1.4× 77 0.8× 83 0.9× 90 1.1× 34 877

Countries citing papers authored by Bup‐Woo Kim

Since Specialization
Citations

This map shows the geographic impact of Bup‐Woo Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bup‐Woo Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bup‐Woo Kim more than expected).

Fields of papers citing papers by Bup‐Woo Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bup‐Woo Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bup‐Woo Kim. The network helps show where Bup‐Woo Kim may publish in the future.

Co-authorship network of co-authors of Bup‐Woo Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Bup‐Woo Kim. A scholar is included among the top collaborators of Bup‐Woo Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bup‐Woo Kim. Bup‐Woo Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kim, Soo Young, Seok‐Mo Kim, Jun Won Kim, et al.. (2020). Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis. Frontiers in Endocrinology. 11. 599–599. 10 indexed citations
3.
Kim, Soo Young, Seok‐Mo Kim, Özer Makay, et al.. (2020). Transoral endoscopic thyroidectomy using the vestibular approach with an endoscopic retractor in thyroid cancer: experience with the first 132 patients. Surgical Endoscopy. 34(12). 5414–5420. 32 indexed citations
4.
Kim, Soo Young, Seok‐Mo Kim, Hojin Chang, et al.. (2019). Cost for treatment and follow‐up of thyroid cancer increases according to the severity of disease. Head & Neck. 41(7). 2376–2379. 10 indexed citations
5.
Kim, Soo Young, Seok‐Mo Kim, Hojin Chang, et al.. (2019). Lateral neck metastases in the ipsilateral and contralateral compartments of papillary thyroid carcinoma located in one lobe. ANZ Journal of Surgery. 89(11). E498–E501. 6 indexed citations
6.
Kim, Soo Young, Seok‐Mo Kim, Hojin Chang, et al.. (2019). Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea. Frontiers in Endocrinology. 10. 384–384. 34 indexed citations
7.
Lee, Yong Sang, Seok‐Mo Kim, Bup‐Woo Kim, et al.. (2018). Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells. Neoplasia. 20(2). 197–206. 36 indexed citations
8.
Lee, Yong Sang, Soo Young Kim, Soon Won Hong, et al.. (2018). Ultrasonographic features and clinicopathologic characteristics of macrofollicular variant papillary thyroid carcinoma. Medicine. 97(9). e8105–e8105. 5 indexed citations
9.
Jung, Kyong Yeun, Seok‐Mo Kim, Min Joo Kim, et al.. (2018). Genotypic characteristics and their association with phenotypic characteristics of hereditary medullary thyroid carcinoma in Korea. Surgery. 164(2). 312–318. 5 indexed citations
10.
Kim, Soo Young, Seok‐Mo Kim, Bup‐Woo Kim, et al.. (2018). SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer. BMC Cancer. 18(1). 956–956. 21 indexed citations
11.
Kim, Seok‐Mo, Soo Young Kim, Bup‐Woo Kim, et al.. (2018). Treatment Outcomes of Brain metastasis from Papillary Thyroid Cancer. 34(1). 9–13. 1 indexed citations
12.
Kim, Soo Young, Seok‐Mo Kim, Hojin Chang, et al.. (2017). Long-term outcomes of ethanol injection therapy for locally recurrent papillary thyroid cancer. European Archives of Oto-Rhino-Laryngology. 274(9). 3497–3501. 25 indexed citations
13.
Kim, Soo Young, Seok‐Mo Kim, Hojin Chang, et al.. (2017). Transoral Endoscopic Thyroidectomy by a Vestibular Approach with Endoscopic Retractor. 4(3). 1 indexed citations
14.
Park, Ki Cheong, Seok‐Mo Kim, Jeong Yong Jeon, et al.. (2017). Synergistic Activity of N-hydroxy-7-(2-naphthylthio) Heptanomide and Sorafenib Against Cancer Stem Cells, Anaplastic Thyroid Cancer. Neoplasia. 19(3). 145–153. 16 indexed citations
15.
Kim, Bup‐Woo, Soo Young Kim, Yong Sang Lee, et al.. (2017). Parathyroid score can predict the duration of required calcium supplementation after total thyroidectomy. PLoS ONE. 12(3). e0174088–e0174088. 9 indexed citations
16.
Kim, Seok‐Mo, et al.. (2015). Recovery from Permanent Hypoparathyroidism After Total Thyroidectomy. Thyroid. 25(7). 830–833. 39 indexed citations
17.
Lee, Min‐Hsien, Kyung‐Yul Lee, Tae Joo Jeon, et al.. (2015). Frequent visualization of thyroglossal duct remnant on post-ablation 131I-SPECT/CT and its clinical implications. Clinical Radiology. 70(6). 638–643. 7 indexed citations
18.
Kim, Seok‐Mo, Ki Cheong Park, Jeong Yong Jeon, et al.. (2015). Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer. BMC Cancer. 15(1). 1003–1003. 20 indexed citations
19.
Kim, Seok‐Mo, Hojin Chang, Bup‐Woo Kim, et al.. (2014). Tuberculosis cervical lymphadenopathy mimics lateral neck metastasis from papillary thyroid carcinoma. ANZ Journal of Surgery. 86(6). 495–498. 7 indexed citations
20.
Chang, Hojin, Seok‐Mo Kim, Bup‐Woo Kim, et al.. (2013). Clinicopathologic features of solid variant papillary thyroid cancer. ANZ Journal of Surgery. 84(5). 380–382. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026